Navigation Links
Beacon Announces Agreement With New Fortune 500 Pharmaceutical Client
Date:4/14/2011

LOUISVILLE, Ky., April 14, 2011 /PRNewswire/ -- Beacon Enterprise Solutions Group, Inc. (OTC BB:  BEAC) (www.askbeacon.com), an emerging global leader in the design, implementation and management of high performance Information Technology Systems (ITS), today announces the signing of a third US-based Fortune 500 global pharmaceutical client.

(Logo:  http://photos.prnewswire.com/prnh/20101021/DA85933LOGO)

Beacon has been selected by this global pharmaceutical client to provide planning, design and engineering services for its global data center.  Although the name of this client and exact project details are confidential at the request of the client, this new agreement represents further penetration within the Pharmaceutical vertical market by Beacon.  This project will utilize Beacon's data center design expertise relating to ITS infrastructure, data equipment and mechanical / electrical systems.  Beacon is expected to complete this project in the late third quarter of this fiscal year, which ends September 30, 2011.

"The signing of another Fortune 500 client is the beginning of new growth and momentum for our company, following our decision last year to refocus on our core business," stated Bruce Widener, Chairman and CEO of Beacon.  "Our success with other large companies in the pharmaceutical vertical allows Beacon to leverage our core expertise for ITS services and drive revenue in this vertical market segment where we expect increased activity in fiscal 2011."

"The medical and pharmaceutical industries contain a high-density of sophisticated technology systems, which historically have been serviced by a patchwork quilt of local and regional services firms," stated Jerry Bowman, President and COO of Beacon.  "Beacon has a demonstrated history of providing clear value and market leadership
'/>"/>

SOURCE Beacon Enterprise Solutions Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Researchers Use Nanoparticles as Destructive Beacons to Zap Tumors
2. IDEV Announces Full Canadian Regulatory Approval for SUPERA VERITAS®
3. Solta Medical Announces First Quarter 2011 Results Release and Conference Call
4. Amgen Announces Webcast of 2011 First Quarter Financial Results
5. Award Winning Vascular Imaging Device Company Announces New Patents
6. ThermoGenesis Announces Registration of Res-Q in India; Commercial Sales Expected to Begin in Current Quarter
7. Medco Announces Date for Release of First-Quarter 2011 Financial Results
8. BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
9. Life Technologies Announces an Automated Sample Preparation System for its Ion PGM™ Sequencer
10. Marinus Pharmaceuticals Announces U.S. Department of Defense Grant to Study Ganaxolone in Fragile-X Syndrome
11. Perrigo Announces Conclusion of the FDA Re-Inspection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... RIDGEFIELD, Conn. , May 17, 2013 /PRNewswire/ ... discussion in respiratory disease at the American Thoracic ... Philadelphia, PA , May 17 – 22. ... a product approved for the treatment of chronic ... inhalation powder)], as well as investigational compounds for ...
(Date:5/17/2013)... 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 inhibitor ... both dose groups. The primary endpoint assessed the proportion ... with data reported in previous trials, the most common ... results will be presented at an upcoming medical congress. ...
(Date:5/17/2013)... May 17, 2013  Boston Scientific Corporation (NYSE: ... annual EuroPCR Scientific Program May 21-24 in ... present a particularly rich and diversified set of data ... , M.D., global chief medical officer, Boston Scientific.  ... presented, including the NG PROMUS trial, which evaluated our ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
... Feb. 8, 2011 IPC The Hospitalist Company, Inc. (Nasdaq: ... practice company, announced today that it will report results for ... Monday, March 7, 2011, after the market close. ... 5:00 p.m. ET (2:00 p.m. PT) on March 7, 2011 ...
... and IRVINE, Calif., Feb. 8, 2011 ... MASI ) jointly announced today a ... Masimo rainbow® SET Pulse CO-Oximetry™ technology platform a ... product line-up—providing clinicians with a host of innovative ...
Cached Medicine Technology:IPC The Hospitalist Company, Inc. to Report Fourth Quarter 2010 Results 2Welch Allyn Establishes Strategic Partnership to Incorporate Masimo rainbow® SET Noninvasive Measurement Capabilities in Next-Generation Patient Monitors 2Welch Allyn Establishes Strategic Partnership to Incorporate Masimo rainbow® SET Noninvasive Measurement Capabilities in Next-Generation Patient Monitors 3Welch Allyn Establishes Strategic Partnership to Incorporate Masimo rainbow® SET Noninvasive Measurement Capabilities in Next-Generation Patient Monitors 4Welch Allyn Establishes Strategic Partnership to Incorporate Masimo rainbow® SET Noninvasive Measurement Capabilities in Next-Generation Patient Monitors 5Welch Allyn Establishes Strategic Partnership to Incorporate Masimo rainbow® SET Noninvasive Measurement Capabilities in Next-Generation Patient Monitors 6
(Date:5/19/2013)... New York (PRWEB) May 19, 2013 ... in a federal litigation now underway in U.S. District ... Case Management Order dated May 3rd, the Court has ... Nominee Pool to eight cases rather than four. The ... scheduled for Thursday, May 23rd. (In re: Actos Product ...
(Date:5/19/2013)... Grinding your teeth at night can ... annoying your spouse. At the same time, according to ... and Teeth Grinding Could Be a Sign of Sleep ... be hard to prevent. Apparently, Obstructive Sleep Disorder (OSD) ... its symptoms is a habit of teeth grinding along ...
(Date:5/19/2013)... 19, 2013 These molecular diagnostics ... UK, Spain, Japan, Italy, Germany and France:, ... diagnostics laboratory practice, as well as key economic, ... market impact during the next five years. , ... biochip technologies, test formats, detection methodologies, trends in ...
(Date:5/19/2013)... May 19, 2013 The Pradaxa lawyers ... Conference was recently convened for hundreds of Pradaxa ... now underway in U.S. District Court, Southern District of ... website on May 14th, the Conference addressed the status ... reported during the Conference that Defendants submitted a list ...
(Date:5/19/2013)... Chertok now provides gum disease patients with a new alternative ... of a healthier smile. Laser gum surgery or ... diseased gum tissue in patients, but it also stimulates bone ... , LANAP uses a laser to successfully treat and ... healthy tissue as well as encourage new bone growth. With ...
Breaking Medicine News(10 mins):Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2
... ... disseminating information on dentistry,s role in the recognition and management of snoring and sleep apnea, ... second month in a row. , ... New York, NY (PRWEB) July 31, 2009 -- Snoring Isn,t Sexy, LLC, a company ...
... WASHINGTON, July 30 Speaker Nancy Pelosi released the following statement ... will give the Food and Drug Administration (FDA) new enforcement tools ... The House passed the bill this evening by a vote of ... deserve to have confidence that the food they are feeding their ...
... , Calls on Senate to Follow ... president and CEO Pamela G. Bailey today commended the members of the ... Enhancement Act of 2009. The bill passed the House by a ... Food Safety Enhancement Act of 2009 marks an important milestone," said Ms. ...
... papillomavirus infection linked to better prognosis, research suggests , ... human papillomavirus (HPV) may improve survival in patients with ... said the finding may explain why black Americans, who ... head and neck cancer survival rates. , "There is ...
... , , WASHINGTON, July ... Representatives Subcommittee on Research and Science Education, part of the larger ... testified on its contributions as a private sector company in a ... technology, engineering and mathematics (STEM) education. , , ...
... DETROIT, July 30 The following is a statement ... , Congressman Thaddeus McCotter is misguided in his attempts ... the Cambridge Police Department. If Congressman McCotter is interested in ... apology to the citizens of Michigan for the current state of ...
Cached Medicine News:Health News:SnoringIsntSexy.com Tops 21,000 Site Visits for Second Month in a Row 2Health News:GMA Applauds U.S. House for Passage of Landmark Food Safety Bill 2Health News:Virus May Affect Survival in Head and Neck Cancer 2Health News:Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education 2Health News:Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education 3
... Used retrograde to ... establish a Peel-Away ureteral ... The temporary protective Peel-Away ... away as the ureteroscope ...
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
Used during the performance of balloon dilation procedures to inflate and deflate the balloon and measure the pressure within the balloon during the procedure. Supplied sterile in peel-open packages....
Medicine Products: